NEW YORK (GenomeWeb News) – Houston-based genomics and genetics testing firm Gene By Gene has inked an agreement with the University of Texas MD Anderson Cancer Center to become one if its affiliated clinical labs, the company said today.

Gene By Gene said that, under the agreement, scientists at its Genomic Research Center will provide clinical phase instruction, training, and supervision for MD Anderson's Molecular Genetic Technology Program, which is one of the undergraduate education programs at the MD Anderson School of Health Professions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.